Kamada Ltd. Share Price TEL AVIV STOCK EXCHANGE
Stocks
IL0010941198
Pharmaceuticals
| Market Cap | 1.24B 124B 412M 362M 335M 308M 582M 39.37B 595M 4B 1.56B 19.34B 1.55B 1.51B 66.88B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 1.24B 124B 412M 362M 335M 308M 582M 39.37B 595M 4B 1.56B 19.34B 1.55B 1.51B 66.88B | EV / Sales 2026 * |
2.13x | EV / Sales 2027 * | 1.94x |
| Free-Float |
54.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Kamada Ltd.
| 1 day | -0.53% |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir London
CEO | Chief Executive Officer | 57 | 30/06/2015 |
Chaime Orlev
DFI | Director of Finance/CFO | 55 | 30/12/2017 |
Eran Nir
COO | Chief Operating Officer | 53 | 31/10/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 64 | 23/12/2019 |
Leon Recanati
CHM | Chairman | 77 | 06/03/2013 |
David Tsur
BRD | Director/Board Member | 75 | 12/12/1990 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.53% | -1.04% | - | - | 409M | |
| -0.22% | +1.35% | +16.79% | -7.70% | 67.61B | |
| -0.63% | -9.21% | +37.82% | +200.20% | 51.6B | |
| +0.36% | +40.00% | +40.00% | +40.00% | 43B | |
| -1.26% | -0.39% | -49.63% | -53.84% | 40.94B | |
| +4.96% | -3.28% | +55.75% | -24.71% | 29.4B | |
| -1.85% | -15.99% | +99.20% | -46.78% | 27.09B | |
| -2.12% | -2.25% | +66.54% | +82.33% | 23.32B | |
| -0.67% | +1.48% | +10.61% | +188.35% | 19.92B | |
| -2.12% | -3.72% | +61.37% | +126.08% | 16.91B | |
| Average | -0.10% | -3.29% | +37.61% | +55.99% | 35.53B | |
| Weighted average by Cap. | -0.01% | -3.06% | +30.96% | +47.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 585M 58.47B 193M 170M 157M 145M 273M 18.49B 280M 1.88B 735M 9.08B 726M 710M 31.41B | 642M 64.19B 212M 187M 173M 159M 300M 20.3B 307M 2.06B 807M 9.97B 797M 780M 34.48B |
| Net income | 72.01M 7.2B 23.82M 20.93M 19.39M 17.83M 33.68M 2.28B 34.43M 231M 90.51M 1.12B 89.4M 87.48M 3.87B | 104M 10.36B 34.28M 30.12M 27.91M 25.66M 48.47M 3.28B 49.55M 333M 130M 1.61B 129M 126M 5.57B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
